Financial Assistance
Scientists and researchers across Australia apply for funding via Expressions of Interest
ACH4 awards grants to a select number of projects each year
Grants
Creating the Opportunity For Research
The continuum of health research into HIV, Hepatitis B, Hepatitis C and HTLV-1 can be viewed as a ‘funnel’ selecting outcomes from a huge range of basic biomedical research, both in Australia and internationally and developing this into potential health care and biotechnology outcomes, which, together with social research leads to health care improvement (see Figure below).
ACH4 encourages basic virology and immunology researchers in the HIV, Hepatitis B, Hepatitis C and HTLV-1 fields to translate their biomedical discoveries into potential health care and biotechnology outcomes and to support clinical research through the development of advanced laboratory tests and the quality control of tests underlying clinical trials. Thus ACH4 funding targets a unique niche in translational research in Australia.
| Research Function | Funding |
|---|---|
| Basic | National and international competitive peer reviewed grants |
| Strategy | National Centres in HIV and Hepatitis Research |
| Clinical (trials) | Industry sources particularly related to developing diagnostics, vaccines and antivirals |
Outcomes from the Grants We Award
- Applications for and/or success in obtaining international grants or NHMRC Development, MRFF, VMRAF or ARC linkage grants based on preliminary data generated from ACH4 work.
- Patents e.g. vaccine candidates, diagnostics, tropical microbicides.
- Commercial Agreements or Licences.
- Other collaborations with commercial companies.
- Deployment of diagnostic tests (e.g. rapid HIV diagnostic tests)
- Novel assays used in clinical trials.
- Enhance collaborations between HIV and hepatitis researchers in Australia.
- Significant public health outcomes (e.g. molecular epidemiology to identify and treat outbreaks)
